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Abstract
Molecular analysis of bacterial 16S rRNA genes has made a significant contribution to the identification and characterisation
of bacterial flora in the human gut. In particular, this methodology has helped characterise bacterial families implicated in
the aetiology of inflammatory bowel disease (IBD). In this study we have used a genus specific bacterial 16S PCR to
investigate the prevalence and diversity of Pseudomonas species derived from the ileum of children with Crohn’s disease
(CD), and from control children with non-inflammatory bowel disease (non-IBD) undergoing their initial endoscopic
examination. Fifty eight percent of CD patients (18/32) were positive using the Pseudomonas PCR, while significantly fewer
children in the non-IBD group, 33% (12/36), were PCR positive for Pseudomonas (p,0.05, Fischer’s exact test). Pseudomonas
specific 16S PCR products from 13 CD and 12 non-IBD children were cloned and sequenced. Five hundred and eighty one
sequences were generated and used for the comparative analysis of Pseudomonas diversity between CD and non-IBD
patients. Pseudomonas species were less diverse in CD patients compared with non-IBD patients. In particular P.aeruginosa
was only identified in non-IBD patients.
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Introduction
Crohn’s disease (CD) is a chronic inflammatory condition of the
gastrointestinal tract, predominantly affecting the ileo-caecal
region. CD is increasing in incidence in numerous countries
throughout the world [1,2,3]. One model of CD suggests that it is
initiated in genetically susceptible individuals by an infectious
agent capable of triggering a breakdown in the regulatory
constraints on the mucosal immune system and leads to an
immune mediated tissue injury. However, the infectious agent(s)
that trigger these responses is unclear. Several putative suscepti-
bility genes have been implicated in CD, including CARD15, IL-
23R and TLR-4 [4,5,6]. The role of CARD15 in sensing bacterial
peptidoglycan, and the association between mutant forms of this
gene and CD, further suggest that micro-organisms may play a key
role in disease aetiology.
Mycobacterium avium subspecies paratuberculosis [7] has been the
most widely implicated aetiological agent of CD [8–10]. Adherent-
Invasive E.coli [11], Listeria monocytogenes [12], Pseudomonas [13,14]
and Yersinia [15] have also been proposed as triggers of CD. Some
authors have also argued that CD results from a loss of tolerance
to the normal flora of the gastrointestinal tract [16]. This
hypothesis is supported by observations that CD does not occur
in gnotobiotic rats, and that some CD patients have significantly
higher antibody levels to commensal gut bacteria [17].
It has also been suggested that CD is the result of dysbiosis i.e.
an imbalance between ‘beneficial’ (non-inflammatory) commensals
and ‘harmful’ (pro-inflammatory) commensals [18]. Using bacte-
rial 16S ribosomal RNA (rRNA) gene sequencing, the accepted
standard of bacterial identification [19], studies have demonstrated
a significant difference in the gut flora of CD patients compared
with control populations, providing support for the dysbiosis
hypothesis [20–22]. Such studies report that members of the
phylum Bacteriodetes and Proteobacteria are increased in CD patients.
A preliminary study reported by Eckburg and Relman using 16S
rDNA PCR also identified significantly more Proteobacteria phylum-
associated 16S rDNA sequences (preliminary E. coli and
Pseudomonas species) from colonic tissue samples obtained from
patients with CD than from non CD patients [23]
Bacteria within the genus Pseudomonas have also been associated
with the development of CD. Several Pseudomonas species are
opportunistic pathogens including P.aeruginosa and P.fluorescens
[25,24]. Some, such as P.aeruginosa and P.putida, are also minor
members of the normal gastrointestinal microbiota [26–28]. Early
studies reported that variants of Pseudomonas-like bacteria were
detected in the gastrointestinal tract of CD patients and found to
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inflammatory bowel disease (IBD) [29–31]. More recently, a T-
cell superantigen (I2), encoded by P.fluorescens, has been associated
with lesions in CD patients [13,14]. However, many of these
studies were performed on adult patients with long standing
disease, who had experienced a variety of treatment regimes,
including antibiotics that would have altered intestinal flora.
A series of preliminary subtractive hybridisation experiments
conducted in our laboratory comparing DNA extracted from CD
and non-IBD gut biopsies detected Pseudomonas specific 16S rDNA
in the differentially expressed populations (Kirkwood, unpublished
observations). These experiments implied that the role of
Pseudomonas species in early onset CD should be investigated further.
Here we present a study investigating the role of Pseudomonas
species in CD and non-IBD paediatric patients presented for initial
diagnosis prior to medical treatment. Specifically, the diversity of
Pseudomonas species in the mucosa of gastrointestinal tracts of
children with and without CD was investigated. We have
conducted a Pseudomonas specific 16S ribosomal analysis on ileal
tissue obtained from CD and non-IBD patients, and subsequently
cloned and sequenced PCR products from each patient. The
resulting Pseudomonas gene libraries were compared using LIB-
SHUFF (LIBrary SHUFFling) analysis [32] and DOTUR
(Distance Based Operational Taxonomic Unit and Richness
Determination) analysis [33].
Results
Identification of Pseudomonas in clinical specimens
obtained from CD and non-IBD patients
Pseudomonas specific 16S (P16S) ribosomal DNA PCR was
performed on DNA extracted from 64 ileal biopsy specimens. Fifty
eight percent of CD patients (18/32) were Pseudomonas positive,
compared with 33% (12/36) non-IBD patients. Statistical analysis
revealed a significant difference between Pseudomonas positive
patients in the CD group compared with the non-IBD group
(p=,0.05, Fisher’s exact test).
Pseudomonas 16S sequences diversity in CD and non-IBD
patients
The diversity of Pseudomonas species present between the two
patient groups was analysed by comparing sequences of the
617 bp P16S PCR products from 13 CD and 12 non-IBD
patients. A minimum of 20 sequences were analysed for each PCR
product, and were used to create a partial P16S gene library for
each patient group. Each library of P16S sequences were aligned
using ClustalW. A PHYLIP generated DNA distance matrix was
calculated using the Jukes-Cantor method and used for LIB-
SHUFF. LIBSHUFF analysis showed that the P16S gene libraries
of CD and non-IBD control patients were significantly different
(p,0.025).
All 581 sequences from the P16S gene library were organised
into operational taxonomic units (OTU) using DOTUR. Each
OTU consists of a group of P16S sequences with 97% sequence
similarity. The P16S sequences were grouped into 6 OTUs of
which five were identified in the CD clone library and all six in the
non-IBD clone library (supporting table S3). Five OTUs were
common to both clone libraries. One OTU was unique to the non-
IBD clone library. The majority of sequences (67.2% CD and
43.3% non-IBD) were found in the OTU 1. The second most
commonly identified sequences were found in OTU 2 (18.8% CD
and 13% non-IBD). OTU 3 sequences were present in 11.3% of
the CD group and in 8.4% of the non-IBD group. OTU 4
represented 10% of sequences in the non-IBD group whilst this
OTU was only a minor fraction within the CD group (0.6%).
OTU 5 sequences were only identified in the non-IBD group
(18%). OTU 6 was the least common type, identified in 7.3% of
non-IBD and 2.2% of CD sequences (Figure 1). The number of
sequences in each individual OTU was tested against the number
of sequences in the remaining OTUs between the two patient
groups using Fischer’s exact test. A significant difference was
identified in OTU 1 and OTUs 4, 5, and 6 between CD and non-
IBD patient groups (p,0.01) (Figure 1 marked with *).
Phylogenetic analysis of Pseudomonas 16S gene library
from CD and non-IBD patients
A consensus sequence of each of the 6 OTUs was generated,
representing the 581 sequences determined from Pseudomonas 16S
PCR products. Figure 2 shows the phylogenetic analysis of each
OTU consensus sequences and sequences from 85 Pseudomonas
reference strains. Each individual OTU clustered into distinct
groups with specific Pseudomonas reference strains. OTU 1 grouped
with P.migulae, P.proteolytica, P.brenneri, and P.panacis. OTU 2
grouped with P.mendocina, P.alcaliphila and P.pseudoalcaligenes.
OTU 3 grouped P.mosselii, P.plecoglossicida and P.monteilii. OTU 4
grouped with P.fragi, P.lundensis, and P.psychrophila. OTU 5 formed
a distinct group with P.nitroreducens and OTU 6 formed a distinct
P.aeruginosa group.
Discussion
In this study we have conducted a molecular analysis using 16S
ribosomal DNA to compare the composition and distribution of
Pseudomonas species identified in ileal specimens obtained from CD
Figure 1. Diversity analysis of Pseudomonas 16S ribosomal sequences obtained from Crohn’s disease patients and non-
inflammatory bowel disease control patients. Five hundred and eighty one sequences from the Crohn’s disease (CD) and non-inflammatory
bowel disease (non-IBD) patient libraries were grouped into operational taxonomic units (OTU) using a sequence similarity threshold of 97%. The
fraction of sequences in each OTU and patient group were calculated and presented. * Significant more sequences in these OTUs compared to the
other patient group (p,0.01, Fisher exact test).
doi:10.1371/journal.pone.0003578.g001
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PLoS ONE | www.plosone.org 2 October 2008 | Volume 3 | Issue 10 | e3578Figure 2. Phylogenetic tree generated from Pseudomonas type strains and consensus sequences from OTUs (OTU1-6) at sequence
similarity threshold of 97%. Bootstrap values are base on 500 replications. The scale bar represents the nucleotide substitution per site. Underlined
reference sequences are known human pathogenic strains. Shadowed box are considered as closely related species within each OTU group.
doi:10.1371/journal.pone.0003578.g002
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studies which reported significant differences in bacterial compo-
sition between IBD and non-IBD patients at higher bacterial
hierarchy levels [20,21,38,39]. In the present study, Pseudomonas
16S (P16S) rDNA was detected in a proportion of ileal biopsy
samples analysed from both patient groups. This is consistent with
previous findings that describe Pseudomonas as normal, low level
members of the gut microbiota [26,28]. Pseudomonas species were
found to be significantly more prevalent in biopsy specimens
obtained from CD patients (58%) when compared to specimens
from non-IBD patients (33%) (p,0.05, Fisher’s exact test). This
finding suggests that there is an altered mucosal environment in
CD patients that favours the growth of Pseudomonas species, which
correlates with previous studies that reported Pseudomonas like
species in CD patients and not in non-IBD patients [29,30].
The P16S sequence libraries between the two patient groups
differed significantly from each other (p,0.025, LIBSHUFF
analysis). To analyse the diversity of Pseudomonas species within
CD and non-IBD libraries, all 581 P16S sequences were grouped
into operational taxonomic units (OTUs). The non-IBD gene
library was more diverse than the CD library with 6 OTUs,
compared to 5 OTUs in the CD library suggesting that the decline
in diversity may occur early in onset disease. All patients used in
this study were children, with an average age of 11.7 years. Thus,
environmental factors (such as smoking and oral contraceptive use)
which typically affect studies on adults with CD, are unlikely to
have significantly affected the data [40,41]. These results were not
confounded by prolonged treatment with anti-inflammatory drugs
or antibiotics since all patients were recruited at initial clinical
examination.
Differences in the distribution of Pseudomonas species were
identified in the CD and non-IBD P16S libraries. The proportion
of sequences found in 4 of 6 OTUs were significantly different
between the groups (p,0.01, Fischer’s exact test). This shifting in
numbers of different Pseudomonas species between patient groups
might contribute to an imbalance between beneficial and harmful
microbiota leading to the inflammatory changes seen in CD.
It is widely recognised that Pseudomonas is a very diverse group of
bacteria, with many species capable of causing human disease.
Pathogenic species are contained within each OTU were identified
in this study. For example, P.migulae, reported to be present in
joints in patients with chronic reactive arthritis [42] was within
OTU 1. While P.pseudoalcaligenes, an organism isolated from
respiratory tract culture of cystic fibrosis patients [43] was within
OTU2. P.mosselii and P.monteilii species were closely related to
sequences within OTU 3. These novel species were isolated from
clinical specimens such as urine, sputum, placenta, skin, and
bronchial samples [44]. The pathogenic strain P.fluorescens
indentified in OTU 4 has been postulated to be implicated in
CD [13,14]. However, our study does not support a role for
P.fluorescens in CD since there was a significant reduction in species
within the OTU 4 group in CD compared with non-IBD patients.
The most striking finding of the P16S sequence analysis was the
complete lack of Pseudomonas species within OTU 5 in the CD
patients, while OTU 5 represented 18% of species in the non-IBD
patients. Sequences in OTU 5 were restricted to Pseudomonas
aeruginosa. The loss of commensal P.aeruginosa in CD patients may
result in dysbiosis, and could play a role in CD. P.aeruginosa is
known to inactivate several pro-inflammatory cytokines [45]. In
other settings, P.aeruginosa has been reported to be implicated in
causing human disease, including chronic granulomatous disease
in paediatric patients [46] and as a trigger in cystic fibrosis [47].
The worldwide increase in the prevalence of CD has been
associated with an increased use of refrigeration [48]. There are no
studies on whether changes in psychotropic bacteria (able to grow at
the temperatures maintained inside a refrigerator, 21t o+10 degrees)
occur in CD populations.Inthis study, OTU1 thatincluded the non-
pathogenic species P.panacis and P.brennerii (reported to be present in
refrigerated beef [49]) was more prevalent in CD patients than in
non-IBD patients. The presence of these species in CD in relation to
disease manifestation requires further investigation.
The imbalance in Pseudomonas species seen in our study might be
a secondary consequence of defective mucosal barrier function
and microbial killing present in IBD patients [50]. This could have
led to an aggressive T-cell response and changed the composition
of Pseudomonas species early in disease progression. Numerous
studies have demonstrated changes in bacterial composition
between beneficial and harmful bacterial species in IBD and
non-IBD patients. This dysbiosis hypothesis is accompanied by a
decrease in microbial diversity in active IBD [20,21,38,39,51,52],
similar what was observed with Pseudomonas in this study.
Pseudomonas is one of the most complex genera of Gram-negative
bacteria with a wide range of natural habitats which might partly
explain their presence in human gut. By using Pseudomonas 16S
ribosomal analysis no single Pseudomonas species was identified as a
causative agent of CD. However, Pseudomonas species were
detected more frequently in CD patients and the Pseudomonas
population in these patients was significantly less diverse when
compared to that of non-IBD patients. Of particular interest was
the lack of P.aeruginosa detected in the gut of CD patients. The
dysbiosis between Pseudomonas species and other gut microbiota
could be directly involved in CD manifestation or be a secondary
consequence after establishment of disease in these children.
Finally, much of the gastrointestinal microbiota remains
uncharacterised [53]. It is likely that many of the sequences
detected in this study represent novel Pseudomonas species/strains.
Full Pseudomonas ribosomal gene analysis (16S–23S) could provide
more insights into specific Pseudomonas species associated with CD.
Whilst the results of this study accurately represent a part of the
bacteriology of active CD, this study did not address the important
role that the immune system and immunological tolerance may
play in CD. Specifically, it remains possible that an inappropriate




Patients undergoing an initial endoscopy at the Royal Children’s
Hospital, Melbourne, Australia for a clinical diagnosis of inflam-
matory bowel disease (IBD) were enrolled in this study. All of the
patients had exhibited symptoms consistent with IBD. None of the
patients had received antibiotics, immunosuppressives drugs or
glucocorticosteroids prior to endoscopy. A total of 68 patients were
included in this study, 32 children were diagnosed with Crohn’s
disease (CD) and 36 children were diagnosed with no pathological
abnormalities (non-IBD). Mucosal biopsy specimens obtained from
the ileum were used for all analyses. The presence or absence of
granulomas was recorded for each CD patient. A detailed
description of patient characteristics is listed in supporting tables
S1 and S2, and includes presence of granulomas, inflammation, sex
and age. Both patient groups had a mean age of 12 years. All tissue
specimens were collected and placed immediately into a sterile
screw-cap cryotube containing 0.5 ml of RNAlater [Ambion]. The
samples were stored at 270uC until DNA extraction. Samples were
examined in the order in which they were collected, so that CD and
non-IBD cases were examined in a random manner. The clinical
diagnosis of CD was established using standard clinical and
Pseudomonas 16S in Children
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confirmed by histological examination of gut tissue. Ethics approval
for the study was obtained from the Human Ethics Committee of
the Royal Children’s Hospital (EHRC no. 23003). Written
informed consent was obtained from each individual, parent or
guardian prior to enrolment in the study.
DNA extraction from biopsy specimens
Tissue samples (3–6 mm
3) were homogenised using a sterile plastic
pestle in 200 ml of lysis buffer (20 mM Tris-HCl, pH 8.0 and 2 mM
EDTA). The homogenate was subjected to three cycles of freeze/
thaw. Lysozyme (20 mg/ml, Sigma) was added to each sample and
incubated at 37uC for 30 minutes. A volume of 600 ml buffer AL
(QIAamp DNA mini kit, Qiagen) and glass beads (,20%, diameter
150–212 microns, Sigma) were added to each sample and subjected
to mechanical disruption in a FastPrep (setting of 6.5 ms
22 for
45 seconds). Glass beads were removed and supernatant was treated
with proteinase K (24 mAU) incubated at 56uC for 2 hours with
vortexing 2–3 times per hour. DNA was extracted using the QIAamp
DNA mini kit according tothe manufacturer’sinstructions[QIAgen].
In an alternative method DNA was extracted as above except the
freeze/thaw cycles and the FastPrep cycle were omitted. Briefly,
tissue sample was homogenised as above in 200 ml buffer RLT
[QIAgen]. Then two 5 mm sterile glass beads and an additional
400 ml buffer RLT were added and homogenate was incubated for
one hour with 15 seconds vortexing every 10 minutes. Glass beads
were removed and the DNA was extracted using the QIAamp DNA
minikitaccordingtothemanufacturer’sinstructions[QIAgen].DNA
was eluted into 50 ml nuclease free water. Two DNA extraction
methods were employed for 16s rDNA amplification, since studies
conducted in our lab has shown that the use of different extraction
methods can influence the diversity of 16s rDNA sequences obtained
(unpublished observations).
All DNA extractions were conducted in biological safety cabinet
class II. A mock homogenisation and extraction without sample
material was included in each extraction run to exclude
contamination with bacteria during the procedure.
Amplification of Pseudomonas 16S ribosomal DNA
A Pseudomonas specific 16S ribosomal (P16S) PCR (617 bp) was
conducted using Pseudomonas specific primers described by Spilker
et al., [35]. Five ml of purified DNA was used in a 50 ml PCR
reaction. PCR reactions were performed using a final concentra-
tion of 16 PCR Buffer, 2 mM MgCl, 2.5 U Taq polymerase
[Applied Biosystems], 250 mM of each deoxynucleoside triphos-
phate [Invitrogen] and 500 nM of the Pseudomonas genus specific
primers, PA-GS-F (59-GACGGGTGAGTAATGCCTA3-9), and
PA-GS-R (59-CACTGGTGTTCCTTCCTATA-39) [35]. PCR
conditions were: 95uC for 5 minutes, 10 cycles of 94uC for
15 seconds, 53uC for 30 seconds and 72uC for 45 seconds, this
was repeated for another 25 cycles with the exception that the
72uC elongation step was increased by 5 seconds every cycle. A
final extension phase of 72uC for 10 minutes was used. A nested
PCR assay was conducted using all DNA samples which were
negative or weakly positive (not sufficient for gel extraction and
cloning). Universal bacterial 16s primers described by Wang et al.,
[36] were used in the first round PCR. PCR reactions were
performed in a total volume of 50 ml using a final concentration of
16PCR Buffer, 1.5 mM MgCl, 2.5 U Taq polymerase [Applied
Biosystems], 200 mM of each deoxynucleoside triphosphate
[Invitrogen] and 1 mM of universal bacterial primers, 27f (59-
AGAGTTTGATCMTGGCTCAG-39) and 1492r (59-TACGGY-
TACCTTGTTACGACTT-39). PCR conditions were: 95uC for
5 minutes, 40 cycles of 94uC for 30 seconds, 62.5uC for
30 seconds and 72uC for 1 minute. A final extension phase of
72uC for 10 minutes was used. For the second round PCR, 5 mlo f
the first round 16s PCR product was used with Pseudomonas specific
primers (PA-GS-F and PA-GS-R) in a Master Amp PreMix B
buffer [EpiCentre]. PCR conditions were as above except an
annealing temperature of 57uC was used. E.coli DNA was used as a
positive control for the first round and as negative control for the
second PCR. P.aeruginosa and P.putida DNA was used as a positive
control for both rounds of PCR. In all PCR assays a mock
extraction and a negative PCR reaction were included. PCR
products were separated by electrophoresis using a 1% TBE
agarose gel and visualized under UV light using ethidium
bromide. Amplicons of the correct size were extracted from the
agarose gel and purified using a QIAquick Gel Extraction kit
[QIAGEN], according to the manufacturer’s instructions.
Cloning and sequencing of Pseudomonas 16S rDNA
fragments
To evaluate the sequence diversity within the Pseudomonas species,
the P16S rDNA PCR products CD patients and non-IBD patients
were cloned and sequenced. DNA was extracted using the
QIAquick gel extraction kit [QIAgen] and cloned into pCR2.1
vectors [TA Cloning Kit, Invitrogen] and transformed into One
Shot Top 10 chemically competent E.coli [TA Cloning Kit,
Invitrogen], as described by the manufacturer’s instruction. Blue/
white screening was performed and white colonies were replated for
insert confirmation. A minimum of 24 white colonies from each
PCR product were selected and grown overnight at 37uC in 96 well
agar plates. Plates were then sent to the Australian Genome
Research Facility [AGRF, Brisbane, Australia] for culture, plasmid
isolation and bi-directional sequencing using the vector-targeted
M13 forward and reverse primers. Sequencing reactions were
performed with Big Dye version 3.1 on an AB3730x1 sequencing
platform. All sequences were analysed using the Sequencher
program, (version 4.7) to remove low quality data and vector
sequences, and used to prepare consensus sequences of each clone.
Bioinformatics analysis
Consensus sequences were aligned using ClustalW, available
from GenomeNet Computation service from Kyoto University
Bioinformatics Center (http://align.genome.jp). A PHYLIP gen-
erated DNA distance matrix (dnadist) with Jukes-Cantor option
was calculated using the Mobyle Pasteur program suite (http://
mobyle.pasteur.fr). The PHYLIP dnadist matrix was used for
LIBSHUFF gene library comparison and for the generation of
operational taxonomic units using DOTUR. The LIBSHUFF
analysis compares two gene libraries and provides a statistical test
for the null hypothesis to determine if two libraries are significantly
different from one another [32]. In this study webLIBSHUFF
version 0.96 was used (Henrikson, JR. 2004 http://libshuff.mib.
uga.edu). The DOTUR program (http://www.plantpath.wisc.
edu/fac/joh/dotur.html) [33] was used to assess the richness of
Pseudomonas collection associated with biopsy specimens obtained
from CD and non-IBD patients. In our study we compared the
Pseudomonas membership (the list of OTUs in a community) and
the membership structure (the abundance of each OTU) at a 97%
sequence similarity threshold. The number of sequences in each
unique OTU and the proportion of sequences from each patient
group in each unique OTU was calculated and analysed.
Phylogenetic analysis
Phylogenetic analyses was conducted using MEGA version 3.1
(Kumar, Tamura, Nei 2004) [37]. Consensus sequences from each
Pseudomonas 16S in Children
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(version 4.7) and sequences for 85 Pseudomonas reference strains for
use in the phylogenetic tree were obtained from the Ribosomal
Database Project II (release 9.59 at http://rdp.cme.msu.edu). All
sequences were adjusted to 617 bp and OTUs consensus
sequences were aligned with Pseudomonas type strains using
ClustalW from MEGA then a phylogenetic tree was constructed.
Trees were produced by the neighbor-joining program with the
Kimura correction and Boot strapping 500 times.
Statistical analysis
Fisher’s exact test was used to analyse the association between
two binary variables, such as the presence or absence of
Pseudomonas between CD and non-IBD patient groups. Tests were
either one or two tailed and a p value of ,0.05 was considered
significant.
Supporting Information
Table S1 Characteristics of CD and non-IBD control patients
Found at: doi:10.1371/journal.pone.0003578.s001 (0.13 MB
DOC)
Table S2 Summary of patient characteristics
Found at: doi:10.1371/journal.pone.0003578.s002 (0.03 MB
DOC)
Table S3 Summary of OTUs in Pseudomonas 16S gene
libraries.
Found at: doi:10.1371/journal.pone.0003578.s003 (0.04 MB
DOC)
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